Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zynex Inc. (ZYXI:NASDAQ), powered by AI.
Zynex Inc. is currently trading at $0.06. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Zynex Inc. on Alpha Lenz.
Zynex Inc.'s P/E ratio is 0.6.
“Zynex Inc. trades at a P/E of 0.6 (undervalued) with modest ROE of 7.3%. 3Y revenue CAGR of 13.9% highlights clear growth momentum.”
Ask for details →Zynex Inc. is a prominent medical device manufacturer specializing in the development and marketing of non-invasive medical devices for pain management, physical rehabilitation, neurological diagnostics, and cardiovascular monitoring. The company is noted for its cutting-edge electrotherapy products, such as its flagship NexWave device, which aims to provide effective pain relief and muscle stimulation to patients. Zynex Inc. serves a diverse clientele, including hospitals, clinics, and individual healthcare providers, enabling enhanced patient care and recovery outcomes. Its devices are integral in post-operative care and various therapeutic protocols. Founded in 1996 and headquartered in Englewood, Colorado, Zynex Inc. plays a critical role in the healthcare industry by delivering solutions that improve patient quality of life while reducing reliance on pharmaceuticals. Through its innovative approach, Zynex strives to address the growing demand for alternative pain solutions, consequently supporting the broader trend of personalized healthcare management.
“Zynex Inc. trades at a P/E of 0.6 (undervalued) with modest ROE of 7.3%. 3Y revenue CAGR of 13.9% highlights clear growth momentum.”
Ask for details →Zynex Inc. (ticker: ZYXI) is a company listed on NASDAQ in the Healthcare sector (Medical Distribution). It has approximately 1,000 employees. Market cap is $2M.
The current price is $0.055 with a P/E ratio of 0.59x and P/B of 0.05x.
ROE is 7.32% and operating margin is 3.11%. Annual revenue is $192M.